state California state Tennessee hospital wellness stars donates love UPS show state California state Tennessee

'General Hospital' Star John J. York to Return to Show Following Cancer Battle

Reading now: 711
www.justjared.com

John J. York is heading back to General Hospital! The 65-year-old soap star, who was diagnosed with two types of blood and bone marrow cancer, myelodysplastic syndrome and smoldering multiple myeloma in 2022 after a routine checkup, will be returning to the series as Mac Scorpio on June 19.

He made an emotional appearance on Good Morning America to discuss his return, as well as the outpouring of love from the public, including the amount of people who signed up to donate bone marrow after his diagnosis was made public. “I made the announcement and it has helped.

And so many people have-,” he said, pausing while getting choked up “joined the registry, just to help to save someone’s life.” Keep reading to find out more… John is filming episodes of General Hospital now after undergoing cancer treatment, going through seven days a week of chemotherapy at Vanderbilt University in Tennessee before being cleared to fly to California and get back on the set.

In November 2023, he found a perfect 20-year-old bone marrow donor match. “I couldn’t talk,” he emotionally recalled to GMA through tears. John then received a transfusion of the donated bone marrow cells and said he hopes to one day meet and thank his life-saving donor in person. John first announced he’d be taking a hiatus from the show in early September, after playing the role since 1991.

Read more on justjared.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Susan Hopkins - COVID-19 variants identified in the UK – latest updates - gov.uk - Britain - city Oxford
gov.uk
48%
298
COVID-19 variants identified in the UK – latest updates
UKHSA) has published its containing updated analysis of the emergent variant BA.2.86.BA.2.86 continues to transmit within the UK, with sporadic cases identified in most regions.The briefing contains early laboratory data from a number of scientific organisations around the UK, including UKHSA’s own Vaccine Development and Evaluation Centre (VDEC), the University of Oxford, the Glasgow Centre of Virus Research and the Pirbright Institute.This early data indicates that BA.2.86 is no more likely to evade existing antibodies than XBB.1.5, another variant that has been circulating widely in the UK.While the available data remains limited, there is currently no evidence to suggest that BA.2.86 infection is more likely to make people seriously ill than currently-circulating variants, while vaccination is likely to provide continued protection.UKHSA will continue to monitor vaccine effectiveness in the population throughout the winter and will publish updated analysis in due course.Professor Susan Hopkins, Chief Medical Advisor, UKHSA said:While this is still very early data and more research is needed before we can be certain, it is encouraging to see an initial indication that BA.2.86 demonstrates similar levels of antibody escape compared to other variants circulating in the UK. The available data is too limited to draw conclusions about the severity of the illness it causes, but there is so far no evidence to suggest that it is more likely to make people seriously ill than other Omicron variants in circulation.The autumn vaccination programme started this month, and this new data shows once again how important it is that the most vulnerable among us are fully vaccinated in order to receive the greatest possible protection.
DMCA